Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.

Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.

Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| SVP, Regulatory and Quality | GREEN ANDREW M | Sep 3, 2026 | Sell | $38.84K | 1,493 |
| SVP, Regulatory and Quality | GREEN ANDREW M | Sep 2, 2026 | Sell | $177.5K | 6,510 |
| CEO | Mackin James P | Aug 19, 2026 | Sell | $2.03M | 70,000 |
| CFO | Berry Lance A | Aug 14, 2026 | Sell | $20.41K | 715 |
| SVP, Regulatory and Quality | GREEN ANDREW M | Aug 14, 2026 | Sell | $17.59K | 616 |
| SVP, General Counsel | Holloway Jean F | Aug 12, 2026 | Sell | $27.83K | 977 |
| SVP, Regulatory and Quality | GREEN ANDREW M | Jun 11, 2026 | Sell | $289.92K | 14,001 |
| SVP, Regulatory and Quality | GREEN ANDREW M | Jun 11, 2026 | Sell | $620.82K | 30,000 |
| SVP, General Counsel | Holloway Jean F | Mar 4, 2026 | Sell | $340.56K | 8,962 |
| Chief Commercial Officer | Davis John E | Mar 3, 2026 | Sell | $172.75K | 4,573 |
| CFO | Berry Lance A | Mar 3, 2026 | Sell | $238.59K | 6,316 |
| SVP, Clinical & MD Affair | Stanton Marshall S. | Mar 3, 2026 | Sell | $81.18K | 2,149 |
| CEO | Mackin James P | Mar 3, 2026 | Sell | $675.69K | 17,887 |
| VP, Chief Accounting Officer | Horton Amy | Mar 3, 2026 | Sell | $34.04K | 901 |
| SVP, General Counsel | Holloway Jean F | Mar 3, 2026 | Sell | $145.17K | 3,843 |
| SVP, Clinical & MD Affair | Stanton Marshall S. | Mar 2, 2026 | Sell | $57.53K | 1,513 |
| Chief Commercial Officer | Davis John E | Mar 2, 2026 | Sell | $105.86K | 2,784 |
| SVP, General Counsel | Holloway Jean F | Mar 2, 2026 | Sell | $83.01K | 2,183 |
| CEO | Mackin James P | Mar 2, 2026 | Sell | $566.99K | 14,911 |
| VP, Chief Accounting Officer | Horton Amy | Mar 2, 2026 | Sell | $24.37K | 641 |
| CFO | Berry Lance A | Mar 2, 2026 | Sell | $196.89K | 5,178 |
| SVP, General Counsel | Holloway Jean F | Feb 24, 2026 | Sell | $59.54K | 1,668 |
| VP, Chief Accounting Officer | Horton Amy | Feb 24, 2026 | Sell | $29.63K | 830 |
| CEO | Mackin James P | Feb 24, 2026 | Sell | $497.42K | 13,936 |
| Chief Commercial Officer | Davis John E | Feb 24, 2026 | Sell | $74.06K | 2,075 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.